Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Jianhua Shi et al.|The Lancet Respiratory Medicine|2020Cited by 504
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Jianhua Chen et al.|Journal of Thoracic Oncology|2021Cited by 311
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivitySenbo Liu, Zhenqiang Sun, Wenkang Wang et al.|Cell Death and Disease|2023Cited by 130
Roles of exosomes in immunotherapy for solid cancersC. Lyu, Qiming Wang, Haifeng Sun et al.|Cell Death and Disease|2024Cited by 106